122 related articles for article (PubMed ID: 27626783)
1. The silent disease.
Shaw G
Nature; 2016 Sep; 537(7620):S98-9. PubMed ID: 27626783
[No Abstract] [Full Text] [Related]
2. Perspective: What next for treatment?
Motzer RJ
Nature; 2016 Sep; 537(7620):S111. PubMed ID: 27626781
[No Abstract] [Full Text] [Related]
3. Cigarette smoking, von Hippel-Lindau gene mutations and sporadic renal cell carcinoma.
van Dijk BA; Schouten LJ; Oosterwijk E; Hulsbergen-van de Kaa CA; Kiemeney LA; Goldbohm RA; Schalken JA; van den Brandt PA
Br J Cancer; 2006 Aug; 95(3):374-7. PubMed ID: 16892044
[TBL] [Abstract][Full Text] [Related]
4. [VHL, angiogenesis and renal carcinoma: the puzzle is complete].
Richard S
Ann Pathol; 2000 Mar; 20(2):107-9. PubMed ID: 10740003
[No Abstract] [Full Text] [Related]
5. Stat bite: Incidence of and mortality from kidney cancer, 1975-2001.
J Natl Cancer Inst; 2004 Sep; 96(17):1271. PubMed ID: 15339962
[No Abstract] [Full Text] [Related]
6. VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease.
Montani M; Heinimann K; von Teichman A; Rudolph T; Perren A; Moch H
Am J Surg Pathol; 2010 Jun; 34(6):806-15. PubMed ID: 20431476
[TBL] [Abstract][Full Text] [Related]
7. Risk factors, genetic predisposition and mutations in the VHL gene in sporadic renal cell carcinoma: The Netherlands Cohort Study.
Van Dijk BA; Schouten LJ; Hulsbergen-van de Kaa CA; van Houwelingen KP; Schalken JA; Kiemeney LA; Geurts van Kessel AH; Bausch-Goldbohm RA; van den Brandt PA
IARC Sci Publ; 2002; 156():509-10. PubMed ID: 12484247
[No Abstract] [Full Text] [Related]
8. Familial renal cell carcinoma from the Swedish Family-Cancer Database.
Liu H; Sundquist J; Hemminki K
Eur Urol; 2011 Nov; 60(5):987-93. PubMed ID: 21621909
[TBL] [Abstract][Full Text] [Related]
9. Transplant considerations in a man with von Hippel-Lindau disease with bilateral renal cell carcinoma and a pancreatic neuroendocrine tumour.
Leong KG; Kanellis J; Mulley WR
Nephrology (Carlton); 2015 Dec; 20(12):956-7. PubMed ID: 26511773
[No Abstract] [Full Text] [Related]
10. Focus on kidney cancer.
Linehan WM; Zbar B
Cancer Cell; 2004 Sep; 6(3):223-8. PubMed ID: 15380513
[No Abstract] [Full Text] [Related]
11. Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation.
Turner KJ; Moore JW; Jones A; Taylor CF; Cuthbert-Heavens D; Han C; Leek RD; Gatter KC; Maxwell PH; Ratcliffe PJ; Cranston D; Harris AL
Cancer Res; 2002 May; 62(10):2957-61. PubMed ID: 12019178
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of tumorigenesis of renal carcinomas associated with the constitutional chromosome 3;8 translocation.
Schmidt L; Li F; Brown RS; Berg S; Chen F; Wei MH; Tory K; Lerman I; Zbar B
Cancer J Sci Am; 1995; 1(3):191-5. PubMed ID: 9166475
[TBL] [Abstract][Full Text] [Related]
13. [Tumor suppressor gene VHL, hypoxia inducible factor, and renal cell carcinoma].
Zhang YT; Chen N; Zeng H; Zhou Q
Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):562-4. PubMed ID: 17134554
[No Abstract] [Full Text] [Related]
14. Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions.
Gallou C; Chauveau D; Richard S; Joly D; Giraud S; Olschwang S; Martin N; Saquet C; Chrétien Y; Méjean A; Correas JM; Benoît G; Colombeau P; Grünfeld JP; Junien C; Béroud C
Hum Mutat; 2004 Sep; 24(3):215-24. PubMed ID: 15300849
[TBL] [Abstract][Full Text] [Related]
15. VHL gene mutation and clear-cell renal carcinomas.
Knudson AG
Cancer J Sci Am; 1995; 1(3):180-1. PubMed ID: 9166471
[No Abstract] [Full Text] [Related]
16. [Prevention of renal carcinoma: the nutri-genetic approach].
Junien C; Dupret JM; Gallou C; Longuemaux S; Richard S; Saquet C; Krishnamoorty R; Delomenie C; Droz D; Bouvier R; Chauveau D; Joly D; Grunfeld JP; Chretien Y; Mejean A; Beroud C
J Soc Biol; 2000; 194(1):29-38. PubMed ID: 11107547
[TBL] [Abstract][Full Text] [Related]
17. Radiological evaluation, management, and surveillance of renal masses in Von Hippel-Lindau disease.
Meister M; Choyke P; Anderson C; Patel U
Clin Radiol; 2009 Jun; 64(6):589-600. PubMed ID: 19414081
[TBL] [Abstract][Full Text] [Related]
18. Progress in the management of advanced renal cell carcinoma (RCC).
Tong TQ; Rohde D; Peter S
Aktuelle Urol; 2010 Jan; 41 Suppl 1():S57-60. PubMed ID: 20094957
[TBL] [Abstract][Full Text] [Related]
19. [Current progress in the diagnosis and treatment of renal cell carcinoma].
Tsukamoto T; Takahashi A; Kitamura H
Nihon Jinzo Gakkai Shi; 2002 Dec; 44(8):779-85. PubMed ID: 12607966
[No Abstract] [Full Text] [Related]
20. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation.
Lovell M; Lott ST; Wong P; El-Naggar A; Tucker S; Killary AM
Cancer Res; 1999 May; 59(9):2182-9. PubMed ID: 10232606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
